Clinical Trial Update: Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 trial update evaluating iadademstat in combination with atezolizumab or durvalumab for extensive-stage small cell lung cancer; study currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Durvalumab (durvalumab)
• Iadademstat (iadademstat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1, Phase 2 | Status: RECRUITING